Simon Lowth will leave AstraZeneca plc (NYSE:AZN) (LON:AZN) where he has been chief financial officer since 2007 for the same position at BG Group plc (OTCMKTS:BRGYY) (LON:BG), Reuters reports. AstraZeneca plc (NYSE:AZN) (LON:AZN) has struggled with falling profits as many of its drug patents have expired, opening up competition from generic drug manufacturers, and CEO Pascal Soriot has said that the company is looking to recover profits in the long-term. Lowth served as interim CEO from June to October of last year when Soriot was recruited from rival Roche Group. Previous CEO David Brennan was forced from the position by investors…
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
